FROM TRADITIONAL MEDICINE TO MODERN THERAPEUTICS:THE CARDIOMETABOLIC POTENTIAL OF PURSLANE

Portulaca oleracea L., commonly known as purslane, is an edible and medicinal plant belonging to the family Portulacaceae. Owing to its nutritional richness and diverse pharmacological properties, it has attracted considerable scientific interest as a potential source of bioactive compounds with relevance to human health. The plant contains several biologically active constituents, including alpha-linolenic acid, flavonoids, alkaloids, polysaccharides, phenolic compounds and essential nutrients. Experimental investigations and emerging clinical evidence have demonstrated its potential antioxidant, anti-inflammatory, hypoglycemic, hypolipidemic and cardioprotective activities. These biological effects may be associated with the modulation of glucose homeostasis, lipid metabolism, oxidative stress, inflammatory responses, blood pressure regulation and endothelial function. Consequently, increasing attention has been directed towards its potential role in the prevention and management of cardiometabolic disorders, including metabolic syndrome, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD) and associated cardiovascular complications. However, the translation of these promising findings into clinical applications remains challenging due to variations in plant preparation, extraction methods, dosage, treatment duration and study designs, as well as inconsistencies in reported outcomes. Furthermore, concerns regarding its oxalate content, bioavailability and long-term safety highlight the need for more comprehensive investigations. This review critically examines the botanical characteristics, traditional uses, phytochemical composition, pharmacological properties and underlying molecular mechanisms of Portulaca oleracea L., with particular emphasis on its potential benefits for cardiovascular and metabolic health. It also evaluates the existing experimental and clinical evidence, identifies major research gaps and discusses future perspectives to establish its therapeutic relevance and potential as a complementary approach to the management of cardiometabolic disorders.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24415242
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

FROM TRADITIONAL MEDICINE TO MODERN THERAPEUTICS:THE CARDIOMETABOLIC POTENTIAL OF PURSLANE

Anjali M. Wanegaonkar, Nuzhat Ansari, shrutika patil, Vaishnavi Dhavan et al.
Zenodo (CERN European Organization for Nuclear Research)
Natural Antidiabetic Agents Studies
article

FROM TRADITIONAL MEDICINE TO MODERN THERAPEUTICS:THE CARDIOMETABOLIC POTENTIAL OF PURSLANE

Anjali M. Wanegaonkar, Nuzhat Ansari, shrutika patil, Vaishnavi Dhavan, Sairaj Mulghe, Bhavik Shinde
article en

Abstract

Portulaca oleracea L., commonly known as purslane, is an edible and medicinal plant belonging to the family Portulacaceae. Owing to its nutritional richness and diverse pharmacological properties, it has attracted considerable scientific interest as a potential source of bioactive compounds with relevance to human health. The plant contains several biologically active constituents, including alpha-linolenic acid, flavonoids, alkaloids, polysaccharides, phenolic compounds and essential nutrients. Experimental investigations and emerging clinical evidence have demonstrated its potential antioxidant, anti-inflammatory, hypoglycemic, hypolipidemic and cardioprotective activities. These biological effects may be associated with the modulation of glucose homeostasis, lipid metabolism, oxidative stress, inflammatory responses, blood pressure regulation and endothelial function. Consequently, increasing attention has been directed towards its potential role in the prevention and management of cardiometabolic disorders, including metabolic syndrome, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD) and associated cardiovascular complications. However, the translation of these promising findings into clinical applications remains challenging due to variations in plant preparation, extraction methods, dosage, treatment duration and study designs, as well as inconsistencies in reported outcomes. Furthermore, concerns regarding its oxalate content, bioavailability and long-term safety highlight the need for more comprehensive investigations. This review critically examines the botanical characteristics, traditional uses, phytochemical composition, pharmacological properties and underlying molecular mechanisms of Portulaca oleracea L., with particular emphasis on its potential benefits for cardiovascular and metabolic health. It also evaluates the existing experimental and clinical evidence, identifies major research gaps and discusses future perspectives to establish its therapeutic relevance and potential as a complementary approach to the management of cardiometabolic disorders.

Zenodo (CERN European Organization for Nuclear Research)
Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College (IN)
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon